Literature DB >> 18289081

The de novo synthesis of oligosaccharides: application to the medicinal chemistry SAR-study of digitoxin.

Maoquan Zhou1, George O'Doherty.   

Abstract

To address the medicinal chemist's need for new synthetic methods for the preparation of unnatural carbohydrates, a new de novo method for carbohydrate synthesis has been developed. These routes use a palladium catalyzed glycosylation reaction to stereoselectively control the anomeric center and subsequent diastereoselective post glycosylation to install the remaining sugar stereocenters. The utility of this method was demonstrated by the syntheses and biological evaluation of several digitoxin oligosaccharide analogues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18289081     DOI: 10.2174/156802608783378828

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  15 in total

Review 1.  Automated Chemical Oligosaccharide Synthesis: Novel Approach to Traditional Challenges.

Authors:  Matteo Panza; Salvatore G Pistorio; Keith J Stine; Alexei V Demchenko
Journal:  Chem Rev       Date:  2018-06-28       Impact factor: 60.622

2.  Influence of Sugar Amine Regiochemistry on Digitoxigenin Neoglycoside Anticancer Activity.

Authors:  Jianjun Zhang; Larissa V Ponomareva; Nitin S Nandurkar; Yaxia Yuan; Lei Fang; Chang-Guo Zhan; Jon S Thorson
Journal:  ACS Med Chem Lett       Date:  2015-08-12       Impact factor: 4.345

3.  Digitoxin and a synthetic monosaccharide analog inhibit cell viability in lung cancer cells.

Authors:  Hosam A Elbaz; Todd A Stueckle; Hua-Yu Leo Wang; George A O'Doherty; David T Lowry; Linda M Sargent; Liying Wang; Cerasela Zoica Dinu; Yon Rojanasakul
Journal:  Toxicol Appl Pharmacol       Date:  2011-10-18       Impact factor: 4.219

4.  Synthesis and Evaluation of the α-D-/α-L-Rhamnosyl and Amicetosyl Digitoxigenin Oligomers as Anti-tumor Agents.

Authors:  Hua-Yu Leo Wang; Yon Rojanasakul; George A O'Doherty
Journal:  ACS Med Chem Lett       Date:  2011-04-14       Impact factor: 4.345

5.  Digitoxin analogues with improved anticytomegalovirus activity.

Authors:  Hongyi Cai; Hua-Yu L Wang; Rajkumar Venkatadri; De-Xue Fu; Michael Forman; Sumit O Bajaj; Hongyan Li; George A O'Doherty; Ravit Arav-Boger
Journal:  ACS Med Chem Lett       Date:  2014-01-25       Impact factor: 4.345

6.  De Novo Asymmetric Synthesis and Biological Analysis of the Daumone Pheromones in Caenorhabditis elegans and in the Soybean Cyst Nematode Heterodera glycines.

Authors:  Haibing Guo; James J La Clair; Edward P Masler; George O'Doherty; Yalan Xing
Journal:  Tetrahedron       Date:  2016-03-16       Impact factor: 2.457

7.  A Direct Comparison of the Anticancer Activities of Digitoxin MeON-Neoglycosides and O-Glycosides: Oligosaccharide Chain Length-Dependent Induction of Caspase-9-Mediated Apoptosis.

Authors:  Anand Krishnan V Iyer; Maoquan Zhou; Neelam Azad; Hosam Elbaz; Leo Wang; Derek K Rogalsky; Yon Rojanasakul; George A O'Doherty; Joseph M Langenhan
Journal:  ACS Med Chem Lett       Date:  2010-07-12       Impact factor: 4.345

8.  A novel use of gentamicin in the ROS-mediated sensitization of NCI-H460 lung cancer cells to various anticancer agents.

Authors:  Michael F Cuccarese; Amit Singh; Mansoor Amiji; George A O'Doherty
Journal:  ACS Chem Biol       Date:  2013-10-17       Impact factor: 5.100

9.  Monosaccharide digitoxin derivative sensitize human non-small cell lung cancer cells to anoikis through Mcl-1 proteasomal degradation.

Authors:  Varisa Pongrakhananon; Todd A Stueckle; Hua-Yu Leo Wang; George A O'Doherty; Cerasela Zoica Dinu; Pithi Chanvorachote; Yon Rojanasakul
Journal:  Biochem Pharmacol       Date:  2013-11-11       Impact factor: 5.858

10.  Potential antitumor activity of digitoxin and user-designed analog administered to human lung cancer cells.

Authors:  Reem Eldawud; Alixandra Wagner; Chenbo Dong; Neha Gupta; Yon Rojanasakul; George O'Doherty; Todd A Stueckle; Cerasela Zoica Dinu
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-07-15       Impact factor: 3.770

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.